MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,078,413 | -33.0% | 48,469 | +6.0% | 0.60% | -52.6% |
| Q2 2023 | $10,565,709 | -72.7% | 45,739 | -65.7% | 1.27% | -78.7% |
| Q4 2022 | $38,693,808 | +269.4% | 133,312 | -17.3% | 5.97% | +191.5% |
| Q3 2022 | $10,474,000 | -0.8% | 161,163 | -4.1% | 2.05% | -0.5% |
| Q2 2022 | $10,554,000 | -30.0% | 168,003 | -22.0% | 2.06% | +12.8% |
| Q1 2022 | $15,072,000 | +6.1% | 215,316 | +28.4% | 1.82% | +11.2% |
| Q4 2021 | $14,208,000 | +8.0% | 167,661 | +1.7% | 1.64% | +0.3% |
| Q3 2021 | $13,154,000 | -18.1% | 164,860 | 0.0% | 1.64% | -50.7% |
| Q2 2021 | $16,059,000 | +21.9% | 164,860 | +46.4% | 3.32% | +0.2% |
| Q1 2021 | $13,171,000 | +4.5% | 112,604 | -0.8% | 3.31% | +40.6% |
| Q4 2020 | $12,608,000 | -7.4% | 113,464 | -1.0% | 2.35% | -46.1% |
| Q3 2020 | $13,614,000 | +2.5% | 114,661 | -2.3% | 4.37% | -3.9% |
| Q2 2020 | $13,288,000 | – | 117,331 | – | 4.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |